The closure by Alphamin of a mine in the DRC has seen tin prices jump to eight-month highs of US$34,815 a tonne and proved a boon to other producers, including Metals X.
Race Oncology has been given ethics approval for a Phase I trial of RC220 bisantrene alone and in combination with doxorubicin in adult solid tumour patients.